CN102949643B - Ointment for skin nursing and dermatitis treatment - Google Patents
Ointment for skin nursing and dermatitis treatment Download PDFInfo
- Publication number
- CN102949643B CN102949643B CN201210450180.4A CN201210450180A CN102949643B CN 102949643 B CN102949643 B CN 102949643B CN 201210450180 A CN201210450180 A CN 201210450180A CN 102949643 B CN102949643 B CN 102949643B
- Authority
- CN
- China
- Prior art keywords
- parts
- ointment
- skin
- dermatitis
- cortex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 47
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 22
- 230000000474 nursing effect Effects 0.000 title claims abstract description 13
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 12
- 244000130592 Hibiscus syriacus Species 0.000 claims abstract description 12
- 235000018081 Hibiscus syriacus Nutrition 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 239000004615 ingredient Substances 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 13
- 241000334161 Cercis chinensis Species 0.000 claims description 12
- 241001604597 Pyrestini Species 0.000 claims description 12
- 241000237903 Hirudo Species 0.000 claims description 11
- 241000623906 Lytta vesicatoria Species 0.000 claims description 11
- 241001161070 Calomela Species 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 238000012545 processing Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000004380 ashing Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 229940099259 vaseline Drugs 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 27
- 210000004369 blood Anatomy 0.000 abstract description 25
- 239000008280 blood Substances 0.000 abstract description 24
- 208000003251 Pruritus Diseases 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 12
- 238000001816 cooling Methods 0.000 abstract description 3
- 230000007803 itching Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241001124216 Cicindelinae Species 0.000 abstract 1
- 244000223060 Erythrina herbacea Species 0.000 abstract 1
- 235000005280 Erythrina herbacea Nutrition 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241000219295 Portulaca Species 0.000 abstract 1
- 241000417534 Stemona sessilifolia Species 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 229940075397 calomel Drugs 0.000 abstract 1
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 33
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 10
- 201000008937 atopic dermatitis Diseases 0.000 description 9
- 206010012438 Dermatitis atopic Diseases 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 206010012442 Dermatitis contact Diseases 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 208000002474 Tinea Diseases 0.000 description 5
- 241000130764 Tinea Species 0.000 description 5
- 206010000496 acne Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 208000010247 contact dermatitis Diseases 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 208000008742 seborrheic dermatitis Diseases 0.000 description 5
- 150000003431 steroids Chemical class 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 231100000915 pathological change Toxicity 0.000 description 4
- 230000036285 pathological change Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000001840 Dandruff Diseases 0.000 description 3
- 241000545442 Radix Species 0.000 description 3
- 241001180876 Saposhnikovia Species 0.000 description 3
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 3
- 206010041303 Solar dermatitis Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- NJICGAVMYWKCMW-GWJXCKMPSA-N Dipterocarpol Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4CC[C@@H]3[C@]21C NJICGAVMYWKCMW-GWJXCKMPSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- -1 Humuleno Chemical class 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 201000009053 Neurodermatitis Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 241000517307 Pediculus humanus Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 241000223238 Trichophyton Species 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- CJGSNPCDEYCMDA-UHFFFAOYSA-N 2-[(dimethylamino)methyl]-4-fluoro-6-methylphenol Chemical compound CN(C)CC1=CC(F)=CC(C)=C1O CJGSNPCDEYCMDA-UHFFFAOYSA-N 0.000 description 1
- NJICGAVMYWKCMW-UHFFFAOYSA-N 20 R-Hydroxydammarenon Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC(C(C)(O)CCC=C(C)C)C4CCC3C21C NJICGAVMYWKCMW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- PFCVZKFJHRCLCC-MTYXOXLRSA-N Alphitolic acid Natural products CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@@H](CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O PFCVZKFJHRCLCC-MTYXOXLRSA-N 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 241000197194 Bulla Species 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- UFJPCTSKTPSJTK-UHFFFAOYSA-N Dryobalanone Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC(C(O)(CO)CCC=C(C)C)C4CCC3C21C UFJPCTSKTPSJTK-UHFFFAOYSA-N 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010016936 Folliculitis Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010024438 Lichenification Diseases 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- PSZDOEIIIJFCFE-UHFFFAOYSA-N Oleanolic alcohol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C)(C)CC5C4=CCC3C21C PSZDOEIIIJFCFE-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 206010040867 Skin hypertrophy Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 241001480046 Trichophyton schoenleinii Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940124623 antihistamine drug Drugs 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 229960003657 dexamethasone acetate Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000550 effect on aging Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- PSZDOEIIIJFCFE-OSQDELBUSA-N erythrodiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C PSZDOEIIIJFCFE-OSQDELBUSA-N 0.000 description 1
- HTZRWCSRPTWJCT-UHFFFAOYSA-N erythrodiol Natural products CC1(C)CCC2(CO)CCC3C(CCC4C3(C)CCC5C(C)(C)C(O)CCC45C)C2C1 HTZRWCSRPTWJCT-UHFFFAOYSA-N 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000002864 mononuclear phagocyte Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 208000002440 photoallergic dermatitis Diseases 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 229930193551 sterin Natural products 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an ointment for skin nursing and dermatitis treatment, belonging to the field of traditional Chinese medicine. The effective ingredients of the ointment comprise the following raw materials by a weight proportion: 20-30 parts of pericarpium citri reticulatae, 20-30 parts of shrubalthea bark, 15-25 parts of radix sileris, 15-25 parts of variegated coralbean bark, 15-25 parts of portulaca, 12-22 parts of cortex kadsurae radicis, 8-15 parts of rhizoma pinelliae preparatum, 8-12 parts of calomel, 8-12 parts of caulis spatholobi, 7-12 parts of stemona sessilifolia, 6-12 parts of tiger beetle, 8-12 parts of acanthopanax, 6-12 parts of rhizoma atractylodis, 6-10 parts of herba asari, 3-8 parts of leech, and 4-8 parts of borneol. According to the ointment, traditional Chinese medicine is adopted, the clinical application shows that the ointment has the effects of expelling wind, nourishing blood, eliminating dampness, relieving itching, cooling blood, and detoxifying; and the ointment has the advantages of good assimilation effect, remarkable curative effect, safety, reliability, and zero toxic and side effects. The clinical application proves that the ointment has a wide curative scope of dermatitis, and a higher cure rate.
Description
Affiliated technical field
The present invention relates to the field of Chinese medicines, relate in particular to a kind of ointment for skin nursing and treatment dermatitis.
Background technology
Along with the quickening of modern life rhythm, people's operating pressure is increasing, the tired and spiritual burden of work, make a part of crowd for a long time in sub-health state, be that QI and blood is weak, fatiguability, thereby also easily suffer from the inflammation of skin aspect, or skin easily old and feeble, follow the string.
Owing to causing skin to occur that the reason of inflammation is varied, the form of expression of inflammation is also different, according to modern medicine study, roughly has atopic dermatitis, contact dermatitis, neurodermatitis, solar dermatitis and seborrheic dermatitis.
Atopic dermatitis is that one is intractable, chronic, inflammatory skin is sick, and position spreads all over face, neck, elbow, poples, extremity dorsal part etc., and affected part there will be erythema, skin thickening, coarse situation.Atopic dermatitis can show effect and the hard to bear pruritus of patient Chang Yinwei and grab scarredly with it repeatedly, not only affects outward appearance, and even emotion and sleep all can be affected, and greatly affect the quality of the life of individual and family.Atopic dermatitis etiology unknown, influence factor is numerous, relate to the factors such as crowd, area, race, atopic dermatitis is taking the oral medicine of external steroid ointment machin antihistaminic as main at present, life-time service may produce the sequela such as atrophoderma, micro cautery expansion, adrenal gland's inhibition, pathobolism, secondary infection and immunity degradation, spreads upon around eyes and even may cause glaucoma.
Contact dermatitis refers to that human body contacts after certain material, a kind of scytitis occurring because of allergy or intense stimulus on skin or mucosa.Chinese medicine is named respectively according to the difference of contactant, as " contact dermatitis of buttock ", " dermatitis rhus ", " contact dermatitis from plaster ", " acne vulgaris " etc.Its occurrence cause can be divided into constitutional to stimulate and two kinds of allergy, shows as the even necrosis etc. of erythema, vesicle, bulla more.Because stimulus object is uncertain, thus its treatment is difficult for and uncertain therapeutic efficacy fixed.
Neurodermatitis claims again chronic lichen, is commonly considered as due to cortex inhibition and excited dysfunction, and emotion local excitation and pungent drinks can increase the weight of and bring out primary disease, does not heal throughout the year, rear easily recurrence, clinical show as violent pruritus or skin lichen sample pathological changes more.
Solar dermatitis is a kind of Delayed onset photoallergy dermatoses photo-induced by day.Someone thinks and is mainly caused by ultraviolet B radiation, and also someone thinks and is mainly caused by long wave ultraviolet.Clinical manifestation is pleomorphism erythra, can have erythema, pimple, vesicle, erosion, squama, lichenification, often taking certain erythra as main.
Seborrheic dermatitis, the traditional Chinese medical science is referred to as " seborrhea ichthyosis ", is a kind of inflammatory skin disease that betides seborrhea position, is apt to occur in the sebaceous gland more place that distributes, as scalp, face, chest and gauffer portion.Seborrheic dermatitis be it is generally acknowledged relevant with body constitution, belongs to chronic disease, easily outbreak repeatedly, and often with folliculitis, blepharitis, the normal and acne of face, rosacea acarid dermatitis are concurrent.
Oral drugs for scytitis on sale or external-applied ointment in the market, be generally steroid or antihistamine drug, all kinds of different skin inflammation of the cause of disease is lacked to treatment specific aim, especially multiple dermatitis stimulates with nervous system, patient's body constitution is relevant, and curative effect especially can not be satisfactory.In addition, even if dispenser is suited the medicine to the illness, be only often also the generation that has suppressed inflammation, the skin injury that morbidity is caused, lacks and repairs nursing function.
Therefore, market demand has the scytitis medication for the treatment of scytitis and skin nursing dual-use function concurrently.
Summary of the invention
The invention provides a kind of ointment for skin nursing and treatment dermatitis, there is dispelling wind and nourish blood, removing damp to relieve itching, effect of removing pathogenic heat from blood and toxic substance from the body, for achieving the above object, technical scheme of the present invention is implemented as follows:
For an ointment for skin nursing and treatment dermatitis, raw material composition and the parts by weight of making described ointment effective ingredient are:
15～25 parts of 15～25 parts of Cortex erythrinaes of 20～30 parts of Radix Saposhnikoviaes of 20～30 parts of Shrubalthea Barks of Cortex Moutan
8～12 parts of 8～15 parts of Calomelass of 12～22 parts of Rhizoma Pinelliae Preparatum of 15～25 parts of Cortex cercis chinensiss of Herba portulacae
8～12 parts of 6～12 parts of Radix Et Caulis Acanthopanacis Senticosis of 7～12 parts of Chinese blister beetle of class of 8～12 parts of Radixs Stemonae of Caulis Spatholobi
4～8 parts of 3～8 parts of Borneolum Syntheticums of 6～10 portions of Hirudos of 6～12 parts of Herba Asaris of Rhizoma Atractylodis
Raw material composition and the parts by weight of making described ointment effective ingredient are:
20～23 parts of 18～22 parts of Cortex erythrinaes of 22～28 parts of Radix Saposhnikoviaes of 22～28 parts of Shrubalthea Barks of Cortex Moutan
8～12 parts of 10～12 parts of Calomelass of 14～18 parts of Rhizoma Pinelliae Preparatum of 18～22 parts of Cortex cercis chinensiss of Herba portulacae
9～12 parts of 8～10 parts of Radix Et Caulis Acanthopanacis Senticosis of 8～10 parts of Chinese blister beetle of class of 8～12 parts of Radixs Stemonae of Caulis Spatholobi
5～6 parts of 4～6 parts of Borneolum Syntheticums of 7～10 portions of Hirudos of 8～11 parts of Herba Asaris of Rhizoma Atractylodis
Raw material composition and the parts by weight of making described ointment effective ingredient are:
21 parts of 20 parts of Cortex erythrinaes of 25 parts of Radix Saposhnikoviaes of 24 parts of Shrubalthea Barks of Cortex Moutan
10 parts of 11 parts of Calomelass of 16 parts of Rhizoma Pinelliae Preparatum of 20 parts of Cortex cercis chinensiss of Herba portulacae
11 parts of 9 parts of Radix Et Caulis Acanthopanacis Senticosis of 9 parts of Chinese blister beetle of class of 10 parts of Radixs Stemonae of Caulis Spatholobi
5 parts of 5 parts of Borneolum Syntheticums of 9 portions of Hirudos of 10 parts of Herba Asaris of Rhizoma Atractylodis
A preparation method for skin nursing with the ointment for the treatment of dermatitis, comprises following processing step:
(1) Radix Stemonae is put into container, add the ethanol of 4 times of amounts, soak taking liquid after 2～3 hours, be condensed into the thick paste of relative density 1.20～1.22 at 60 DEG C.
(2) Herba portulacae ashing is ground into powder, crossed 120 order fine powders, for subsequent use.
(3) Cortex Moutan, Shrubalthea Bark, Radix Saposhnikoviae, Cortex erythrinae, Cortex cercis chinensis, Rhizoma Pinelliae Preparatum, Calomelas, Caulis Spatholobi, Chinese blister beetle of class, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Atractylodis, Herba Asari, Hirudo and Borneolum Syntheticum are pulverized and ground into powder, cross 120 order fine powders, for subsequent use.
(4) mix homogeneously with step (2), step (3) gained fine powder making thick paste in step (1), add appropriate crab oil and vaseline, stir into ointment.
The property of medicine of the present invention's Chinese medicine used is as follows:
Cortex Moutan: cold in nature, bitter in the mouth; Cool; Be slightly cold.GUIXIN; Liver; Kidney channel.Clearing away heat and cooling blood; Promoting blood circulation to remove blood stasis; Send out speckle; Tell nosebleed; Carbuncle sore tumefacting virus.Modern medicine study proves, its extract has antibacterial anticoagulant, improve blood permeability, promote that mononuclear phagocyte plays a role, the decomposition of the lipocyte due to resistance epinephrine, promote that glucose generates fat in lipocyte, increase glucose due to insulin and generate the multiple effect of fat, treatment acute eczema is had to remarkable effectiveness.
Shrubalthea Bark: property sweetness and bitterness, gas are put down; Temperature, nontoxic.Enter the heart, lung, spleen, stomach four warps.Heat clearing away, dampness removing, removing toxic substances, antipruritic, tonifying the lung eliminating dampness by diuresis, reduces phlegm and internal heat, tranquilizing mind, easing joint movement, blood circulation promoting regulates qi, dispelling, collateral-activating pain relieving.
Radix Saposhnikoviae: slightly warm in nature, pungent, gas and, nontoxic.Enter bladder, lung, spleen channel.Expelling pathogenic wind from the body surface; Removing dampness to relieve pain; Spasmolytic; Antipruritic.Modern medicine study confirmation, Radix Saposhnikoviae press liquor has certain antibacterial action to bacillus pyocyaneus and staphylococcus aureus.
Cortex erythrinae: property toil, flat, enter liver, spleen channel.Wind-damp dispelling, the meridian dredging, parasite killing, controls scabies." detailed outline " carries: " network of passing through, reaches disease institute, enters again blood system and removes wind parasite killing " and " south of the Five Ridges gather medicinal herbs record " carries: " granulation promoting, pain relieving, steamed cold noodles skin, detumescence, dissipating blood stasis, deposited traumatic injury ".Modern medicine study proves, Cortex erythrinae water logging agent has inhibitory action in various degree to dermatophytess such as blue trichophyton, oidium schoenleinii, rust microspore's tinea bacterium, epidermophyton inguinales.
Herba portulacae: property acid, cold, acrid in the mouth is nontoxic.Enter large intestine, liver, spleen channel.Heat-clearing and toxic substances removing, cooling blood for hemostasis, loose blood detumescence, treatment of ulcer carbuncle furuncle, scrofula, warm tinea.Tang Materia Medica carries: " main all swollen fistula verruca ".The conventional side of Herba portulacae grinds into powder for ashing, is particularly useful for inflammation skin, can effectively increase the oxidation resistance of Skin Cell, reduces inflammation.
Cortex cercis chinensis: property hardship, flat, temperature, has micro-poison.Enter liver, spleen two warps.Promoting blood circulation to restore menstrual flow, subduing swelling and detoxicating, controls anemofrigid-damp arthralgia, vim and vigour pain, sore throat, drenches disease, carbuncle, tinea scabies, traumatic injury, snake bite and insect sting." classification medical herbs " carries: " controlling all carbuncle, sore, multiple abscess, the cold and hot not clear person of all toxic swellings ".Modern medicine study proves, Cortex cercis chinensis has inhibitory action to the PR-1 of capital section virus, can delay its pathological changes to Orphan virus.
Rhizoma Pinelliae Preparatum: property is pungent, warm, is slightly cold, ripe temperature.Enter spleen, stomach warp.Drying dampness to eliminate phlegm, sending down the abnormal ascending QI preventing or arresting vomitting, dissolving lump and resolving mass, outer subduing inflammation." not Lu " carries: " subduing inflammation, treat sallow, happy damp appearance ".
Calomelas: property is pungent, cold, pungent cold and dry, poisonous.Enter liver, kidney channel.Parasite killing, counteracting toxic substances, diuretic, relieving constipation." detailed outline " and " book on Chinese herbal medicine just " carries: " the swollen expansion of harnessing the river, skin infection; Control all skin infection of scrofula, removing the necrotic tissue meat, tissue regeneration promoting meat ".Modern medicine study proves Calomelas effectively killing fungus, to trichophyton, permitted blue achorion, the dermatophytess such as big belly microspore tinea bacterium, epidermophyton rubrum, star-shaped nocardia of shutting out difficult to understand all have inhibitory action in various degree.
Caulis Spatholobi: bitter, sweet, warm in nature.Enter the heart, spleen two warps.Relaxing muscles and tendons to promote blood circulation, nourishing blood for regulating menstruation, powdered medicine ' Tongluosan ' gas." decoction pieces is newly joined " carries: " blood stasis removing blood, tissue regeneration promoting blood, fluent passages through which vital energy circulates.Control summer filthy infection, wind arthralgia due to stagnation of blood disease ".Modern medicine study confirmation, Caulis Spatholobi can promote total phosphorus metabolism in kidney and uterus, to water and muriatic excretion.
The Radix Stemonae: property is sweet, bitter, tepor.Enter lung meridian.Nourishing the lung to keep the adverse QI downward cough-relieving, can effectively kill head louse, body louse, and function cures mainly enterobiasis, pudendal pruritus.Modern medicine study confirmation, Radix Stemonae infusion has certain inhibitory action to some skin pathomycete.
Chinese blister beetle of class: property is pungent, cold.Enter large intestine, small intestinal, liver, kidney channel." herbal classic " carries: " malignant boil cellulitis, loses dead flesh for main cold and heat, scrofula, and broken stone is infirmity.Counteracting toxic substances phagedenoma, removing blood stasis eliminating stagnation, main carbuncle; Scrofula; Stubborn dermatitis; Lump in the abdomen; Be used for stubborn dermatitis for many years, wart, carbuncle is not burst, the dead flesh of malignant boil ".
Radix Et Caulis Acanthopanacis Senticosi: warm in nature, acrid in the mouth, micro-hardship.Relaxing muscles and tendons to promote blood circulation, wind-damp dispelling, replenishing QI to invigorate the spleen, tonifying the kidney for tranquilization.Modern medicine study proves effectively anti-inflammation of its extract, has fabulous defying age effect.
Rhizoma Atractylodis: property is arduous, temperature.Enter spleen, stomach warp.Drying damp and strengthening spleen, expelling wind and cold, for beriberi flaccidity of feet with lamenness, rheumatic arthralgia.Main the spleen and stomach being stranded by dampness, damp-edema; Exterior syndrome is flat wet, with Herba Asari, the same use of Radix Saposhnikoviae." beautiful Chinese catalpa medicine solution " carries: " dry native diuretic, lets out drink expectorant, clots absorbing, and dissipating depression of QI, goes Lou, changes tinea ， Chu Disorder, and reason acid regurgitation removing the necrotic tissue, wards off mountains and rivers communicable subtropical diseases, the flaccidity that returns muscles and bones is soft, the excessive muddiness of urinating clearly ".
Herba Asari: acrid in the mouth, warm in nature, heat.Enter lung, kidney channel.Cold expelling induces sweat; Wind-expelling pain-stopping; Warming the lung to resolve fluid-retention; Sensible." not Lu " carries: " dredging water passages, opens in the heart for warming the middle warmer and descending qi, broken expectorant, except sore throat ， Weng nose, the insane disease of acute infantile convulsion, and stimulating milk secretion knot.Control no sweating, blood is not all right, settling five organs, the liver benefiting gallbladder, logical vital essence ".
Hirudo: salty in the mouth, hardship, property is flat, is slightly cold.Enter liver, bladder two warps.Primary symptom removing blood stasis, removing blood stasis, stimulates the menstrual flow.Control blood-retention, mass in the abdomen, gathers, and Shennong's Herbal carries: " gather raw Chi Ze by stagnant blood blood stasis, removing blood stasis abdominal mass.”
Borneolum Syntheticum: acrid in the mouth hardship, cool, be slightly cold.Enter the heart, lung meridian." detailed outline " carries: " Borneolum Syntheticum leads to all keys, loose stagnated fire.While controlling, disease is sent out smallpox and red skin ulcer, controls wine Zha nose ".Modern medicine study confirms, in Borneolum Syntheticum, contain multiple ter penoids, except Borneolum Syntheticum, still containing sesquiterpenes such as Humuleno, beta-elemene, caryophyllene, the triterpenoids such as oleanolic acid, alphitolic acid, asiatic acid, dipterocarpol, dryobalanone, erythrodiol, have effect of antibacterial anti-inflammatory.
The present invention compared with prior art, has following beneficial effect:
Between each raw material of the present invention, have synergism, all medicines are harmonious and make gas reach blood beniol, have giving consideration to both the incidental and fundamental, the advantage for the treatment of must aim at the pathogenesis of disease.The present invention adopts Chinese medicine, proves through clinical use, and the present invention has dispelling wind and nourishes blood, removing damp to relieve itching, effect of removing pathogenic heat from blood and toxic substance from the body; Good absorbing effect, evident in efficacy, safe and reliable, have no side effect, wide to scytitis therapeutic domain through clinical verification, cure rate is higher.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is further elaborated.
Embodiment 1
Raw material composition and the parts by weight of ointment effective ingredient of the present invention are:
Cortex Moutan 22g Shrubalthea Bark 22g Radix Saposhnikoviae 18g Cortex erythrinae 16g
Herba portulacae 20g Cortex cercis chinensis 16g Rhizoma Pinelliae Preparatum 9g Calomelas 8g
Caulis Spatholobi 10g Radix Stemonae 8g Chinese blister beetle of class 7g Radix Et Caulis Acanthopanacis Senticosi 8g
Rhizoma Atractylodis 8g Herba Asari 9g Hirudo 4g Borneolum Syntheticum 4g
The processing step of process for preparing medicine of the present invention is:
(1) Radix Stemonae is put into container, add the ethanol of 4 times of amounts, soak taking liquid after 2～3 hours, be condensed into the thick paste of relative density 1.20～1.22 at 60 DEG C.
(2) Herba portulacae ashing is ground into powder, crossed 120 order fine powders, for subsequent use.
(3) Cortex Moutan, Shrubalthea Bark, Radix Saposhnikoviae, Cortex erythrinae, Cortex cercis chinensis, Rhizoma Pinelliae Preparatum, Calomelas, Caulis Spatholobi, Chinese blister beetle of class, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Atractylodis, Herba Asari, Hirudo and Borneolum Syntheticum are pulverized and ground into powder, cross 120 order fine powders, for subsequent use.
(4) mix homogeneously with step (2), step (3) gained fine powder making thick paste in step (1), add appropriate crab oil and vaseline, stir into ointment.
Usage and dosage: with after the clean illing skin of clear water or medical alcohol, be evenly applied in skin affected part with the appropriate ointment of cotton swab picking, thickness is advisable with 1～1.5mm, naturally dries.Smearing every day 2 times, every 9 days is a course for the treatment of, and common 1～2 course for the treatment of is effective, and pertinacious disease needs 3～4 courses for the treatment of.
Embodiment 2
Raw material composition and the parts by weight of ointment effective ingredient of the present invention are:
Cortex Moutan 25g Shrubalthea Bark 24g Radix Saposhnikoviae 17g Cortex erythrinae 21g
Herba portulacae 23g Cortex cercis chinensis 18g Rhizoma Pinelliae Preparatum 10g Calomelas 9g
Caulis Spatholobi 10g Radix Stemonae 10g Chinese blister beetle of class 9g Radix Et Caulis Acanthopanacis Senticosi 9g
Rhizoma Atractylodis 8g Herba Asari 9g Hirudo 4g Borneolum Syntheticum 5g
Ointment preparation method processing step and the usage and dosage of the present embodiment are identical with embodiment 1.
Embodiment 3
Raw material composition and the parts by weight of ointment effective ingredient of the present invention are:
Cortex Moutan 25g Shrubalthea Bark 26g Radix Saposhnikoviae 16g Cortex erythrinae 20g
Herba portulacae 22g Cortex cercis chinensis 20g Rhizoma Pinelliae Preparatum 9g Calomelas 10g
Caulis Spatholobi 10g Radix Stemonae 9g Chinese blister beetle of class 8g Radix Et Caulis Acanthopanacis Senticosi 8g
Rhizoma Atractylodis 8g Herba Asari 7g Hirudo 4g Borneolum Syntheticum 5g
Ointment preparation method processing step and the usage and dosage of the present embodiment are identical with embodiment 1.
Embodiment 4
Raw material composition and the parts by weight of ointment effective ingredient of the present invention are:
Cortex Moutan 28g Shrubalthea Bark 28g Radix Saposhnikoviae 20g Cortex erythrinae 22g
Herba portulacae 24g Cortex cercis chinensis 20g Rhizoma Pinelliae Preparatum 12g Calomelas 12g
Caulis Spatholobi 10g Radix Stemonae 11g Chinese blister beetle of class 10g Radix Et Caulis Acanthopanacis Senticosi 10g
Rhizoma Atractylodis 11g Herba Asari 9g Hirudo 6g Borneolum Syntheticum 6g
Ointment preparation method processing step and the usage and dosage of the present embodiment are identical with embodiment 1.
Clinical data:
1, case selection
The routine clinical observation of scytitis patient 150 of selecting my institute's traditional Chinese medical science clinic to make a definite diagnosis, patient is divided into three groups at random, treatment group 50 examples, wherein male's 29 examples, women's 21 examples, 18～55 years old age, 31.6 years old mean age, the shortest person of the course of disease 6 months, elder 9 years, average 4.5 years.Contrast first group 50 examples, wherein male's 32 examples, women's 18 examples, 14～59 years old age, 32.4 years old mean age, the course of disease 7 months～12 years, average 5.9 years.Contrast second group 50 examples, wherein male's 24 examples, women's 26 examples, 16～63 years old age, 38.2 years old mean age, the course of disease 4 months～17 years, average 7.3 years.Three groups of qualifications and record of service are basically identical, without significant difference, have comparability.
2, treatment group patient external medicine of the present invention, adult every day 2 times, is applied in skin affected part, within 9 days, is a course for the treatment of, and common 1～2 course for the treatment of is effective, and pertinacious disease needs 3～4 courses for the treatment of.Contrast first group externally used compound dexamethasone acetate emulsifiable paste, every day 3 times, is applied in skin affected part, within 9 days, is a course for the treatment of.The common various skin inflammation externally-applied ointment of contrast second group external, determines and smears 2～5 times at random, within 9 days, be a course for the treatment of every day.
3, efficacy determination:
(1) recovery from illness: skin pruritus symptom disappears, macroscopic bits shape, musciform exfoliation, herpes, red and swollen phenomenon disappear, and skin colour is normal, flexible.
(2) take a turn for the better: skin pruritus symptom obviously alleviates, macroscopic bits shape, musciform epidermis reduce, and herpes, red and swollen phenomenon obviously alleviate, and skin color is clearly better.
(3) invalid: before symptom and treatment, diagnostic symptom is without obvious visible improvement.
4, result
Smear in the treatment group of ointment of the present invention, cure 42 examples, 6 examples that take a turn for the better, invalid 2 examples, cure rate 84%, total effective rate 96%.
In contrast first group, cure 11 examples, 14 examples that take a turn for the better, invalid 25 examples, cure rate 22%, total effective rate 50%.
In contrast second group, cure 16 examples, 5 examples that take a turn for the better, invalid 29 examples, cure rate 32%, total effective rate 42%
Above result demonstration, the cure rate for the treatment of group and total effective rate are apparently higher than contrast first group and contrast second group.
Model case is given an example:
1, what × ×, female, 17 years old, middle school student.This patient is in first visit in July, 2011.Through inquiry morbidity history, be that skin starts pruritus after putting on the knitted underwear of newly buying, how all cannot to scratch.Patient judges it may is the allergic dermatitis that the underwear of chemical fibre matter causes voluntarily, has then bought the external of steroid ointment in pharmacy and has smeared, and after a couple of days, symptom slightly alleviates but still feel quite discomfort.After external ointment of the present invention, less than 1 course for the treatment of, pruritus symptom all disappears, and heals.
2, turn round and look at × ×, female, 26 years old, white collar.This patient's readme was from 2009, and face and skin of neck start to occur red and swollen phenomenon, with pruritus sensation, after scratching, easily occurred tiny pox shape vesicle with hands.After antiinflammatory Western medicine for oral administration and topical class sterin ointment, remission, scratchiness disappears, but delicate illing skin has left ugly kermesinus mottle originally.After diagnosing, preliminary judgement is contact dermatitis, and after 1 course for the treatment of of external ointment of the present invention, illing skin color dodge, continued to smear after 2 courses for the treatment of, and illing skin has restored to the original state and be flexible.
3, Lee × ×, man, 32 years old, engineer.This patient's readme is because of work relationship, and skin is easily irritated to periods of direct sunlight.Symptom from the beginning of time purchase voluntarily and smear steroid ointment, just started sensation effectively, but not only invalid afterwards, more use on the contrary ointment symptom heavier.When medical, patient's face and both arms exposed part have large area skin, and there is lichen sample pathological changes on surface, and have tiny and many vesicle, vesicle diabrosis place to have erosion and incrustation phenomenon.Tentative diagnosis is solar dermatitis, then uses ointment of the present invention and smears affected part.First course for the treatment of, every day frivolous smearing 3 times, and with monolayer medical gauze hide, first course for the treatment of, while end, all vesicles all formed a scab.Increase the weight of a little ointment consumption second course for the treatment of, smear every day 3 times, remove hospital gauze, second course for the treatment of, while end, lichen sample pathological changes disappeared, and only remained slight pimple shape erythema.Frivolous smearing 2 times, treated skin color while end and substantially recovered normally, to be exposed under daylight and also not recur again the third and fourth every day course for the treatment of.
4, Shen × ×, man, 40 years old, peasant.This patient has atopic dermatitis medical history 4 years, long-term taking western medicine, and symptom had improvement in the time of 39 years old, but recurrence again the year before, the violent pruritus of whole body, and the most serious with extremity, Head And Face and chest and back, the red and swollen heating of illing skin, red pimple is gathered, and thickens desquamation.Be diagnosed as atopic dermatitis or eczema through department of dermatologry, but take multiple Western medicine and outer wiping steroid ointment, all effect is not remarkable, and pruritus situation is serious, scratches all day uncontrollable, even more serious when heat.After 2 courses for the treatment of of external ointment of the present invention, illing skin redness starts to disappear, and scurf amount reduces, and pruritus degree alleviates, and continues to smear after 1 course for the treatment of, and skin color has been tending towards normally, scurf disappearance, pruritus transference cure.
Claims (4)
1. for an ointment for skin nursing and treatment dermatitis, it is characterized in that: raw material composition and the parts by weight of making described ointment effective ingredient are:
2. a kind of ointment for skin nursing and treatment dermatitis according to claim 1, is characterized in that: raw material composition and the parts by weight of making described ointment effective ingredient are:
3. a kind of ointment for skin nursing and treatment dermatitis according to claim 1, is characterized in that: raw material composition and the parts by weight of making described ointment effective ingredient are:
4. a preparation method for the ointment for skin nursing and treatment dermatitis as described in claim 1-3 any one, is characterized in that: comprise following processing step:
(1) Radix Stemonae is put into container, add the ethanol of 4 times of amounts, soak taking liquid after 2～3 hours, be condensed into the thick paste of relative density 1.20～1.22 at 60 DEG C;
(2) Herba Portulacae ashing is ground into powder, crossed 120 order fine powders, for subsequent use;
(3) Cortex Moutan, Shrubalthea Bark, Radix Saposhnikoviae, Cortex erythrinae, Cortex cercis chinensis, Rhizoma Pinelliae Preparatum, Calomelas, Caulis Spatholobi, Chinese blister beetle of class, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Atractylodis, Herba Asari, Hirudo and Borneolum Syntheticum are pulverized and ground into powder, cross 120 order fine powders, for subsequent use;
(4) mix homogeneously with step (2), step (3) gained fine powder making thick paste in step (1), add appropriate crab oil and vaseline, stir into ointment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210450180.4A CN102949643B (en) | 2012-11-07 | 2012-11-07 | Ointment for skin nursing and dermatitis treatment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210450180.4A CN102949643B (en) | 2012-11-07 | 2012-11-07 | Ointment for skin nursing and dermatitis treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102949643A CN102949643A (en) | 2013-03-06 |
| CN102949643B true CN102949643B (en) | 2014-07-16 |
Family
ID=47759402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210450180.4A Expired - Fee Related CN102949643B (en) | 2012-11-07 | 2012-11-07 | Ointment for skin nursing and dermatitis treatment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102949643B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105250850A (en) * | 2015-11-20 | 2016-01-20 | 王秀娟 | External ointment formula for nursing skins and treating dermatitis and preparation method thereof |
| CN111228429A (en) * | 2020-02-24 | 2020-06-05 | 薛飞 | A compound composition containing Chinese medicinal materials and western medicines for treating dermatoses, and its preparation method |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1135994C (en) * | 2000-01-06 | 2004-01-28 | 王乃正 | Exterior-applied Chinese patent medicine for treating gastroenteropathy, gynopathy, arthropath and sore ulcer |
| CN1446531A (en) * | 2002-03-22 | 2003-10-08 | 董景平 | Disinfection attendance liquid prepared from Chinese herbal medicine and its production methods |
| CN101711841A (en) * | 2008-10-08 | 2010-05-26 | 张步天 | Externally-applied liquor for treating dermatosis and preparation method thereof |
-
2012
- 2012-11-07 CN CN201210450180.4A patent/CN102949643B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102949643A (en) | 2013-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20240102982A (en) | Traditional Chinese herbal medicine for the treatment of hives, eczema, allergies/kinetic reactive constitution | |
| CN104288609A (en) | Traditional Chinese medicine composition curing stomach fire flaming gingivitis and preparation method for traditional Chinese medicine composition | |
| CN103735721B (en) | A kind of Chinese medicine treating pink-eye | |
| CN102772591B (en) | Hollow, ventilation and double-layer traditional Chinese medicine suppository for treating rhinitis and production method of traditional Chinese medicine suppository | |
| CN102038923A (en) | Medicament for treating dandruff | |
| CN104324125B (en) | Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof | |
| CN104784346A (en) | Pruritus treating traditional Chinese medicine lotion preparation method | |
| CN101164600A (en) | Medicine for treating acne and whelk | |
| CN104173517A (en) | Traditional Chinese medicine preparation and preparation method for treating primary trigeminal neuralgia | |
| CN103638316B (en) | Traditional Chinese medicine preparation for treating dermatitis | |
| CN102526643B (en) | Chinese herbal medicine buccal tablet for treating dental ulcer | |
| CN103007063B (en) | A pharmaceutical composition for treating facial paralysis, and its preparation method | |
| CN102949643A (en) | Ointment for skin nursing and dermatitis treatment | |
| CN104873911A (en) | Traditional Chinese medicine for oral administration for adjunctively treating sepsis | |
| CN101028425B (en) | Medicine for treating acne | |
| CN103908600A (en) | Externally-applied medicine for treating rheumatoid arthritis damp-heat blockage symptom as well as preparation method and administration method thereof | |
| CN104147378A (en) | Traditional Chinese medicine composition for treating blood-vacuity and wind-dryness type psoriasis | |
| CN104055959A (en) | Traditional Chinese medicine lotion and nursing method for treating gastrointestinal dampness-heat type seborrhoeic dermatitis | |
| CN103705629B (en) | A kind of Chinese medicine composition for the treatment of pruritus | |
| CN105250850A (en) | External ointment formula for nursing skins and treating dermatitis and preparation method thereof | |
| CN102626491B (en) | Externally used Traditional Chinese medicine composition for treatment of lumbar interveterbral disc protrusion | |
| CN104367896A (en) | Pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and preparation method thereof | |
| CN104689235B (en) | A kind of Chinese medicine composition for treating women scapulohumeral periarthritis | |
| CN105012483A (en) | Traditional Chinese medicinal composition for treating head seborrheic dermatitis and preparation method thereof | |
| CN104826068A (en) | Medicine for expelling wind and eliminating dampness and preparation method of medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140716 Termination date: 20141107 |
|
| EXPY | Termination of patent right or utility model |